Abstract:Hepatic fibrosis is a necessary step in the development of hepatic cirrhosis. In this study we used lentiviral vector-mediated transfection technology to evaluate the effect of peroxisome proliferator-activated receptor gamma (PPAR-gamma) on rat hepatic fibrosis.Hepatic fibrosis in rats was induced by CCl4 for 2 weeks (early fibrosis) and 8 weeks (sustained fibrosis). The rats were randomly divided into four groups: normal control, fibrosis, blank vector, and PPAR-gamma. They were infected with the recombinant lentiviral expression vector carrying the rat PPAR-gamma gene by portal vein injection. The liver of the rats was examined histologically and hydroxyproline was assessed. In vitro primary hepatic stellate cells (HSCs) were infected with the recombinant lentiviral expression vector carrying the rat PPAR-gamma gene. The status of HSC proliferation was measured by the MTT assay. The protein levels of PPAR-gamma, alpha-smooth muscle actin (alpha-SMA) and type I collagen expression were evaluated by the Western blotting method.In vitro studies revealed that expression of PPAR-gamma inhibited expression of alpha-SMA and type I collagen in activated HSCs (P<0.01) as well as HSC proliferation (P<0.01). In vivo experiments indicated that in the early hepatic fibrosis group, the hydroxyproline content and the level of collagen I protein in the liver in the PPAR-gamma transfected group were not significantly different compared to the hepatic fibrosis group and the blank vector group; whereas the expressions of PPAR-gamma and alpha-SMA were different compared to the hepatic fibrosis group (P<0.01). In the sustained hepatic fibrosis group, there were significant differences in the hydroxyproline content and the expression of PPAR-gamma, alpha-SMA, and type I collagen between each group.PPAR-gamma can inhibit HSC proliferation and hepatic fibrosis, and suppress alpha-SMA and type I collagen expression.

The Agonists of Peroxisome Proliferator-Activated Receptor-γ for Liver Fibrosis.

Peroxisome Proliferator-Activated Receptor-Γ Cross-Regulation of Signaling Events Implicated in Liver Fibrogenesis

Peroxisome proliferator-activated receptors in the pathogenesis and therapies of liver fibrosis

Differential gene expression in mouse primary hepatocytes exposed to the peroxisome proliferator-activated receptor α agonists

PPARs: Modulating Lipotoxicity and Thus Inhibiting Fibrosis

Therapeutic Potential of PPARγ Natural Agonists in Liver Diseases

Peroxisome proliferator-activated receptor gamma inhibits hepatic fibrosis in rats.

Research advances in peroxisome proliferator activated receptor-γ and renal fibrosis

Targeting Peroxisome Proliferator-Activated Receptors: A New Strategy for the Treatment of Cardiac Fibrosis

PPAR-γ signaling in nonalcoholic fatty liver disease: Pathogenesis and therapeutic targets

Design, synthesis, and biological evaluation of piperazine derivatives as pan-PPARs agonists for the treatment of liver fibrosis

Peroxisome Proliferator-Activated Receptor-γ is Critical to Cardiac Fibrosis.

PPARβ/δ attenuates hepatic fibrosis by reducing SMAD3 phosphorylation and p300 levels via AMPK in hepatic stellate cells

Peroxisome Proliferator-Activated Receptors and Non-Alcoholic Fatty Liver Diseases

Peroxisome proliferator activated receptor gamma ligand suppresses hepatic fibrosis in rats

[Expression and Role of Peroxisome Proliferator-Activated Receptor Gamma and Nuclear Factor-Kappab in Pulmonary Fibrosis].

Peroxisome Proliferator-Activated Receptors Gamma Reverses Hepatic Nutritional Fibrosis in Mice and Suppresses Activation of Hepatic Stellate Cells in Vitro.

Lack of Nogo-B expression ameliorates PPARγ deficiency-aggravated liver fibrosis by regulating TLR4-NF-κB-TNF-α axis and macrophage polarization

Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease

Effect of PPARγ on signal transduction of hepatic stellate cells in liver fibrosis

Peroxisome Proliferator-Activated Receptor (Ppar)-Α: A Pharmacological Target with a Promising Future